Follow this innovation
[ via 
] [?]
Curcumin Analogs with Antitumor and Antiangiogenic Properties
Emory University
posted on 07/07/2009
Applications
Treatment of cancer, inflammation, and related disorders; chemotherapy.
Technical Summary
This invention describes a group of compounds that block tumor angiogenesis and growth without exhibiting a high level of toxicity with regard to normal vascular endothelial cells. The anti-angiogenic and anti-tumor compounds of this invention can be useful in the treatment of any condition benefiting from angiogenesis inhibition, such as cancer and chronic inflammation. In addition, the analogs may be useful for therapy of restenosis that occurs following angioplasty and stent deployment, diabetic retinopathy and other diseases that are caused by aberrant growth of the blood vessels. We anticipate receiving broad patent coverage to pharmaceutical compositions and methods for treatment of cancer.
]]>File Number: 99026
This innovation currently is not available for online licensing. Please contact Cory Acuff at Emory University for more information.
request more info
Principal Investigator:
 |
James Snyder
Innovations (8) Publications (8) |
|---|
Co-Investigators:
|
Dennis Liotta
Innovations (11) |
|---|
|
Eva Ferst
Innovations (1) |
|---|
|
Brian Adams
Innovations (1) |
|---|
|
Mamoru Shoji
Innovations (1) |
|---|
Case Manager:
|
Cory Acuff
Innovations (70) |
|---|
ProfileFind more innovations
